219 related articles for article (PubMed ID: 26391474)
1. Could caregiver reporting adherence help detect virological failure in Cameroonian early treated HIV-infected infants?
Ateba Ndongo F; Warszawski J; Texier G; Penda I; Tetang Ndiang S; Ndongo JA; Guemkam G; Sofeu CL; Kfutwah A; Faye A; Msellati P; Tejiokem MC;
BMC Pediatr; 2015 Sep; 15():132. PubMed ID: 26391474
[TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus infection in HIV-infected versus non-infected infants and HIV disease progression in Cytomegalovirus infected versus non infected infants early treated with cART in the ANRS 12140-Pediacam study in Cameroon.
Kfutwah AK; Ngoupo PA; Sofeu CL; Ndongo FA; Guemkam G; Ndiang ST; Owona F; Penda IC; Tchendjou P; Rouzioux C; Warszawski J; Faye A; Tejiokem MC
BMC Infect Dis; 2017 Mar; 17(1):224. PubMed ID: 28335737
[TBL] [Abstract][Full Text] [Related]
3. Virological failure and antiretroviral resistance among HIV-infected children after five years follow-up in the ANRS 12225-PEDIACAM cohort in Cameroon.
Tagnouokam-Ngoupo PA; Penda IC; Tchatchueng Mbougua JB; Tetang Ndiang S; Yuya Septoh F; Kenne A; Ngallè JE; Jakpou S; Ateba Ndongo F; Warszawski J; Faye A; Tejiokem MC;
PLoS One; 2021; 16(3):e0248642. PubMed ID: 33735301
[TBL] [Abstract][Full Text] [Related]
4. Virologic Response to Early Antiretroviral Therapy in HIV-infected Infants: Evaluation After 2 Years of Treatment in the Pediacam Study, Cameroon.
Ateba Ndongo F; Texier G; Ida Penda C; Tejiokem MC; Tetang Ndiang S; Ndongo JA; Guemkam G; Sofeu CL; Kfutwah A; Faye A; Msellati P; Warszawski J;
Pediatr Infect Dis J; 2018 Jan; 37(1):78-84. PubMed ID: 28841582
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and determinants of virological failure in HIV-infected children on antiretroviral therapy in rural Cameroon: a cross-sectional study.
Zoufaly A; Fillekes Q; Hammerl R; Nassimi N; Jochum J; Drexler JF; Awasom CN; Sunjoh F; Burchard GD; Burger DM; van Lunzen J; Feldt T
Antivir Ther; 2013; 18(5):681-90. PubMed ID: 23502762
[TBL] [Abstract][Full Text] [Related]
6. High level of virological suppression among HIV-infected adults receiving combination antiretroviral therapy in Addis Ababa, Ethiopia.
Mekuria LA; Nieuwkerk PT; Yalew AW; Sprangers MA; Prins JM
Antivir Ther; 2016; 21(5):385-96. PubMed ID: 26731316
[TBL] [Abstract][Full Text] [Related]
7. Time patterns of adherence and long-term virological response to non-nucleoside reverse transcriptase inhibitor regimens in the Stratall ANRS 12110/ESTHER trial in Cameroon.
Meresse M; Carrieri MP; Laurent C; Kouanfack C; Protopopescu C; Blanche J; Cohen J; Laborde-Balen G; Aghokeng AF; Spire B; Moatti JP; Delaporte E; Boyer S;
Antivir Ther; 2013; 18(1):29-37. PubMed ID: 23358393
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of Routinely Offering Early Combined Antiretroviral Therapy to HIV-infected Infants in a Resource-limited Country: The ANRS-PediaCAM Study in Cameroon.
Tejiokem MC; Warszawski J; Ateba Ndongo F; Tetang Ndiang S; Ndongo JA; Owona F; Ngoupo PA; Tchendjou P; Kfutwah A; Penda IC; Faye A
Pediatr Infect Dis J; 2015 Oct; 34(10):e248-53. PubMed ID: 26121199
[TBL] [Abstract][Full Text] [Related]
9. Baseline HIV-1 resistance, virological outcomes, and emergent resistance in the SECOND-LINE trial: an exploratory analysis.
Boyd MA; Moore CL; Molina JM; Wood R; Madero JS; Wolff M; Ruxrungtham K; Losso M; Renjifo B; Teppler H; Kelleher AD; Amin J; Emery S; Cooper DA;
Lancet HIV; 2015 Feb; 2(2):e42-51. PubMed ID: 26424460
[TBL] [Abstract][Full Text] [Related]
10. Comparison of six methods to estimate adherence in an ART-naïve cohort in a resource-poor setting: which best predicts virological and resistance outcomes?
Orrell C; Cohen K; Leisegang R; Bangsberg DR; Wood R; Maartens G
AIDS Res Ther; 2017 Apr; 14(1):20. PubMed ID: 28376815
[TBL] [Abstract][Full Text] [Related]
11. Low Incidence of HIV-1C Acquired Drug Resistance 10 Years after Roll-Out of Antiretroviral Therapy in Ethiopia: A Prospective Cohort Study.
Mulu A; Maier M; Liebert UG
PLoS One; 2015; 10(10):e0141318. PubMed ID: 26512902
[TBL] [Abstract][Full Text] [Related]
12. Which adherence measure - self-report, clinician recorded or pharmacy refill - is best able to predict detectable viral load in a public ART programme without routine plasma viral load monitoring?
Mekuria LA; Prins JM; Yalew AW; Sprangers MA; Nieuwkerk PT
Trop Med Int Health; 2016 Jul; 21(7):856-69. PubMed ID: 27118068
[TBL] [Abstract][Full Text] [Related]
13. Virological failure after 1 year of first-line ART is not associated with HIV minority drug resistance in rural Cameroon .
Zoufaly A; Jochum J; Hammerl R; Nassimi N; Raymond Y; Burchard GD; Schmiedel S; Drexler JF; Campbell NK; Taka N; Awasom C; Metzner KJ; van Lunzen J; Feldt T
J Antimicrob Chemother; 2015 Mar; 70(3):922-5. PubMed ID: 25428920
[TBL] [Abstract][Full Text] [Related]
14. Using a composite adherence tool to assess ART response and risk factors of poor adherence in pregnant and breastfeeding HIV-positive Cameroonian women at 6 and 12 months after initiating option B.
Atanga PN; Ndetan HT; Fon PN; Meriki HD; Muffih TP; Achidi EA; Hoelscher M; Kroidl A
BMC Pregnancy Childbirth; 2018 Oct; 18(1):418. PubMed ID: 30359239
[TBL] [Abstract][Full Text] [Related]
15. Factors Associated with Low-Level Viraemia and Virological Failure: Results from the Austrian HIV Cohort Study.
Leierer G; Grabmeier-Pfistershammer K; Steuer A; Geit M; Sarcletti M; Haas B; Kanatschnig M; Rappold M; Zangerle R; Ledergerber B; Taylor N;
PLoS One; 2015; 10(11):e0142923. PubMed ID: 26566025
[TBL] [Abstract][Full Text] [Related]
16. Virological response and resistance profiles after 24 months of first-line antiretroviral treatment in adults living in Bangui, Central African Republic.
Péré H; Charpentier C; Mbelesso P; Dandy M; Matta M; Moussa S; De Dieu Longo J; Grésenguet G; Abraham B; Bélec L
AIDS Res Hum Retroviruses; 2012 Apr; 28(4):315-23. PubMed ID: 21942692
[TBL] [Abstract][Full Text] [Related]
17. Predictors of faster virological suppression in early treated infants with perinatal HIV from Europe and Thailand.
European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) and Early-treated Perinatally HIV-infected Individuals: Improving Childrenʼs Actual Life with Novel Immunotherapeutic Strategies (EPIICAL) study groups
AIDS; 2019 Jun; 33(7):1155-1165. PubMed ID: 30741823
[TBL] [Abstract][Full Text] [Related]
18. Safety and effectiveness of combination antiretroviral therapy during the first year of treatment in HIV-1 infected Rwandan children: a prospective study.
Mutwa PR; Boer KR; Asiimwe-Kateera B; Tuyishimire D; Muganga N; Lange JM; van de Wijgert J; Asiimwe A; Reiss P; Geelen SP
PLoS One; 2014; 9(11):e111948. PubMed ID: 25365302
[TBL] [Abstract][Full Text] [Related]
19. Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy.
Bisson GP; Gross R; Bellamy S; Chittams J; Hislop M; Regensberg L; Frank I; Maartens G; Nachega JB
PLoS Med; 2008 May; 5(5):e109. PubMed ID: 18494555
[TBL] [Abstract][Full Text] [Related]
20. Accuracy of WHO immunological criteria in identifying virological failure among HIV-infected adults on First line antiretroviral therapy in Mwanza, North-western Tanzania.
Gunda DW; Kidenya BR; Mshana SE; Kilonzo SB; Mpondo BC
BMC Res Notes; 2017 Jan; 10(1):45. PubMed ID: 28095920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
